Default company panoramic image

The Diabetic Boot Company Ltd

A patented class 2 medical device, CE mark Oct 13, FDA 510k in March 14. $1b potential market. Clinical studies begin Oct 13

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Aylesbury, England, GB
  • Currency USD
  • Founded February 2010
  • Employees 2
  • Website

Company Summary

We are a B2B company, selling to stocking distributors in 36 target countries from Q4 2013. Pulseboot® meets a clear clinical need, and will be very cost effective. We have CE mark applied for and a clear predicted pathway to FDA 510k clearance in Q1 2014. We have engaged regulatory and reimbursement experts in the US to plan the US launch. We have clinical support from UK and Global experts. Pulseboot® helps stop diabetic amputations


  • Default avatar
    Les Lindsay

    Experienced Healthcare Market Senior Manager with 28 years experience for blue chip companies such as KCI, BOC, Drager, and DuPont.
    Last role was 8 years running a wound care company that grew from £4m to £26m with 260 employees.
    Excellent contact network throughout Europe, Middle East, and the Americas.

  • Default avatar
    Jes Griffiths
    Director of Operations

    I am a proven General Manager, with detailed experience and interest in Customer Service, Operations, Project Management and Lean/Quality management, not just ISO9001 and ISO13485 but the behavioural aspects of building efficient processes and effective staff.

    Specialties: General Management and member of management teams, especially Customer Service, Operations, Project Management and Lean/Quality

  • Default avatar
    Nick Hyde

    Serial Angel Investor
    Specialties: Mergers and Acquisitions, Manufacturing, Supply chains, Contract Manufacturing, Non-executive Director

  • Default avatar
    Dr Rolf Thomas
    Director of R&D

    Rolf has a PhD from Loughborough in Mechatronic Engineering, and has worked in executive management positions for large medical device companies such as Gyrus. He has experience in gaining regulatory approvals for medical devices.


  • Default avatar
    Kidd Rapinet, London
    Default avatar
    Richardsons, Thame

Previous Investors

  • Default avatar
    Wren Capital
    Default avatar
    Mr Nick Hyde
    Default avatar
    Mr Phil McSweeney